Impact of factors on severity and progression of illness in COVID-19 inpatients at the Eastern Military Hospital

  • Lê Thị Nhàn Bệnh viện Quân dân Y miền Đông
  • Trương Thành Lợi Bệnh viện Quân dân Y miền Đông
  • Trương Hoàng Việt Bệnh viện Quân dân Y miền Đông
  • Hồ Sĩ Dũng Đại học Y khoa Phạm Ngọc Thạch
  • Nguyễn Đức Công Đại học Y khoa Phạm Ngọc Thạch

Main Article Content

Keywords

SARS-CoV-2, COVID-19 infection, COVID-19 patients, COVID-19 vaccine, co-morbidity

Abstract

Objective: To evaluate the effects of the COVID-19 vaccines, ages, gender, BMI, co-morbidity on the severity and progression of illness in COVID-19 inpatients treated at the Eastern Military Hospital from July 2021 to November 2021. Subject and method: Descriptive study on 244 patients hospitalized for treatment at Covid 1 Department of Mien Dong Military Hospital, disease progression (no conversion, conversion but improved treatment, conversion required intensive care). were recorded, and the associations between vaccination, age, sex, BMI, comorbidities and disease severity, time of negative PCR, length of hospital stay, and disease outcome were investigated. Result: The level of patients with mild, moderate and severe - critical in 3 groups included 17.5%, 38.1%, 44.4% in unvaccinated patients, 44.4%, 67.0%, 26.6% in one-dose vaccinated patients, 7.3%, 81.7%, 17.0% two-dose vaccinated and 1.3% (p<0.001). The time of PCR for negative resuls of the 3 groups above were 18.2% ± 3.8, 13.6 ± 2.9 and 12.7 ± 1.9 days, respectively (p<0.001). The duration of inpatient treatment of the 3 groups were 18.65 ± 4.71, 16.13 ± 2.61 and 15.10 ± 1.68 days, respectively (p<0.001). The rate of severe disease requiring intensive care treatment of 3 groups were 20.6%, 5.1% and 0.0%, respectively (p<0.001). Other factors affecting the disease progression of COVID-19 were surveyed including overweight and obesity (p<0.001), hypertension (p=0.003), heart failure (p=0.048), COPD (p=0.038), asthma (p=0.012), tuberculosis (p=0.004), number of underlying diseases ≥ 3 (p=0.001), smoking (p<0.001). Conclusion: Factors such as vaccine, age, sex, BMI, comorbidities, have an effect on the severity of COVID-19 disease, shortening the time of negative PCR and hospital stay, and significantly reducing the conversion rate require active resuscitation.

Article Details

References

1. Wu JT, Leung K, Bushman M et al (2020) Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med 26: 506-510. DOI: 10.1038/s41591-020-0822-7.
2. Shim E, Tariq A, Choi W et al (2020) Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis 93: 339-344. DOI: 10.1016/ j.ijid.2020.03.031.
3. Coronavirus (COVID-19) (2021) Vaccinations. https://ourworldindata.org/covid-vaccinations. Accessed 25 April 2022.
4. Liu Q, Qin C, Liu M et al (2021) Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty 10: 132. DOI: 10.3390/vaccines10020246
5. Meister T, Pisarev H, Kolde R, Kalda R, Suija K, Milani L, Karo-Astover L, Piirsoo M, & Uusküla A (2021) Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia. SSRN Electronic Journal. https://doi.org/10.2139/ ssrn.3955730.
6. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị Covid-19. https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-250-QD-BYT-2022-Huong-dan-chan-doan-dieu-tri-COVID19-502064.aspx. Accessed 25 April 2022.
7. Huang YZ, Kuan CC (2022) Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 26(5): 1770-1776. DOI: 10.26355/eurrev_202203_28248.
8. Lauring AS, Tenforde MW, Chappell JD et al (2022) Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. BMJ 376: 069761 DOI: 10.1136/bmj-2021-069761
9. Singh C, Naik B, Pandey S et al (2021) Effectiveness of COVID-19 vaccine in preventing infection and disease severity: A case-control study from an Eastern State of India. Epidemi and Infect 149: 224. DOI: 10.1017/S0950268821002247.